MFC

MFC makes the active pharmaceutical ingredients (APIs), the chemically synthesized compounds that give a medicine its therapeutic effect, used in treatments for cardiovascular disease, chronic bronchitis, diabetes, and musculoskeletal conditions, among others.

It supplies these ingredients, along with the key starting materials and intermediate compounds needed to produce them, to pharmaceutical manufacturers. Listed on KOSDAQ, Korea's tech and small-cap board, the company covers both established generic-drug ingredients and early-stage novel or improved-drug materials, giving it two distinct business lines within a single chemistry-focused operation.